Hemostasis Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
43
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
1
Hemostasis General Information
Description
Manufacturer of medical device products intended for hemostasis and specifically advanced blood clotting technology. The company offers various products that support hospital and surgical care such as hemostatic powder, foam sponge and hemostat powder, thereby enabling its clients to be provided with quality medical devices that are safe and effective for their intended use.
Contact Information
Website
www.hemostasisllc.com(Operating Subsidiary)
Corporate Office
- 5000 Township Parkway
- Saint Paul, MN 55110
- United States
Corporate Office
- 5000 Township Parkway
- Saint Paul, MN 55110
- United States
Hemostasis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Hemostasis Comparisons
Industry
Financing
Details
Hemostasis Competitors (1)
One of Hemostasis’s competitors is Starch Medical, a Failed Transaction (VC) company based in San Jose, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Starch Medical | Failed Transaction (VC) | San Jose, CA |
Hemostasis Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Hemostasis Patents
Hemostasis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200397605-A1 | Tool for placement of degradeable ostial stent | Active | 19-Jun-2019 | ||
| US-11752020-B2 | Tool for placement of degradable ostial stent | Active | 19-Jun-2019 | ||
| US-20230181342-A1 | Tool for placement of degradeable ostial stent | Active | 19-Jun-2019 | ||
| US-11963896-B2 | Tool for placement of degradeable ostial stent | Active | 19-Jun-2019 | ||
| US-10709585-B2 | Degradeable nasal ostial stent | Active | 15-Sep-2016 | A61F2/82 |
Hemostasis Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Hemostasis Acquisitions (1)
Hemostasis’s most recent deal was a Merger/Acquisition with Fiagon. The deal was made on 13-May-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Fiagon | 13-May-2022 | Merger/Acquisition | Surgical Devices |
Hemostasis Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Fiagon | Hennigsdorf, Germany | 2007 |
Hemostasis FAQs
-
When was Hemostasis founded?
Hemostasis was founded in 2006.
-
Where is Hemostasis headquartered?
Hemostasis is headquartered in Saint Paul, MN.
-
What is the size of Hemostasis?
Hemostasis has 43 total employees.
-
What industry is Hemostasis in?
Hemostasis’s primary industry is Surgical Devices.
-
Is Hemostasis a private or public company?
Hemostasis is a Private company.
-
What is Hemostasis’s current revenue?
The current revenue for Hemostasis is .
-
Who are Hemostasis’s competitors?
Starch Medical is a competitor of Hemostasis.
-
When was Hemostasis acquired?
Hemostasis was acquired on 13-Jan-2023.
-
Who acquired Hemostasis?
Hemostasis was acquired by Baxter International.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
